Alison Edelman M.D., M.P.H., shares insight on the safety and efficacy of Opill, a birth control pill designed to be used safely without a prescription. Edelman was part of the team that studied how the pill performed at baseline and what happens if a dose is missed or taken late. She says, “Progestin-only pills like Opill are safe in most people, which makes them a great option for over-the-counter use.”

Nature reports on news from the United Kingdom that babies have been born in a clinical trial underway to prevent the transmission of mitochondrial disease from parents to children, a type of therapy developed by Shoukhrat Mitalipov, Ph.D., at OHSU.

The Lund Report spoke with OHSU research workers who would like to form a union.

David Spencer, M.D., discusses the importance of patient safety in a first-in-human trial of NRTX-1001 GABAergic interneuron cell therapy for focal epilepsy.

A story about a National Academies report that finds gaps in NIH-supported nonhuman primate research undermine U.S. biomedical research and public health, Jon Hennebold, Ph.D., says: “There has been an increased recognition of the importance of these models in biomedical research,” including studies related to infectious diseases, neuroscience and reproductive and developmental health.

Continued media coverage of Guinness World Records certifying that OHSU dermatologists detected the world’s smallest skin cancer, measuring just .65 millimeters. In an interview with The Washington Post, Alexander Witkowski, M.D., Ph.D., says: “We want to share this knowledge with the next generation as this realm of health care begins to change — I think in a good way.”

Continued media coverage of Guinness World Records certifying that OHSU dermatologists detected the world’s smallest skin cancer, measuring just .65 millimeters. In an interview with The Washington Post, Alexander Witkowski, M.D., Ph.D., says: “We want to share this knowledge with the next generation as this realm of health care begins to change — I think in a good way.”

Exclusive: Mitochondrial donation treatment aims to prevent children from inheriting incurable diseases.

Kathleen Carlson, Ph.D., Ben Hoffman, M.D., and Roy Moore with Portland Opportunities Industrialization Center join Sen. Ron Wyden at an OHSU roundtable discussion aimed at curbing gun violence.

KATU News highlights s Salem Health-OHSU Knight Cancer Institute collaboration to enroll participants in the Pathfinder 2 study, which aims to evaluate a multi-cancer early detection test. Nima Nabavizadeh, M.D., says: “People around Oregon, and in the greater Salem area, will be among the first to have the opportunity to be tested. Being at the forefront of generating new knowledge means we have the ability to bring it to our communities faster.”